ScholarIQanswers from OpenAlex

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

PaperCitations, authors & open-access status

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer have?

ScholarIQcitation count

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer has 1,186 citations in the OpenAlex counts ScholarIQ stores.

When was Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer published?

ScholarIQyear

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer has 2018 year in the ScholarIQ index.

What is the open-access status of Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?

ScholarIQoa status

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer has hybrid oa status in the ScholarIQ index.

What is the DOI of Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?

ScholarIQdoi

The DOI for Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer is on the source record.

What is the PMID of Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?

ScholarIQpmid

The PMID for Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer is on the source record.

What is the OpenAlex record for Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?

ScholarIQopenalex

The OpenAlex for Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial